Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
15.8M
-
Shares change
-
-70K
-
Total reported value, excl. options
-
$611M
-
Value change
-
+$3.44M
-
Put/Call ratio
-
0.38
-
Number of buys
-
56
-
Number of sells
-
-51
-
Price
-
$38.82
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q1 2024
122 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q1 2024.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.8M shares
of 31.6M outstanding shares and own 49.91% of the company stock.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (2.63M shares), Invesco Ltd. (1.63M shares), STATE STREET CORP (1.32M shares), Camber Capital Management LP (853K shares), MORGAN STANLEY (837K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (662K shares), JANUS HENDERSON GROUP PLC (563K shares), Rock Springs Capital Management LP (562K shares), NORTHERN TRUST CORP (384K shares), and Avidity Partners Management LP (361K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.